Effect of different calcineurin inhibitors on AOPP and TAS after kidney transplantation

Clinical Biochemistry

Volumn 43, Issue 6, 2010, Pages 559-565

  Zadražil, Josef ^a   Štrebl, Pavel ^a   Krejčí, Karel ^a   Horčička, Vladko ^a   Horák, Pavel ^a   Vostálová, Jitka ^b   Zdařilová, Adéla ^b   Kajabová, Markéta ^a   Schneiderka, Petr ^a  

^a UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

^b PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

Advanced oxidation protein products; Cardiovascular mortality; Cyclosporine A; Oxidative stress; Renal transplantation; Tacrolimus; Total antioxidant status

Indexed keywords

ADVANCED OXIDATION PROTEIN PRODUCT; CALCINEURIN INHIBITOR; CYCLOSPORIN A; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; CHEMICAL PARAMETERS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; TOTAL ANTIOXIDANT STATUS;

ADULT; AGED; ANTIOXIDANTS; CALCINEURIN; CYCLOSPORINE; ENZYME INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; PROTEINS; TACROLIMUS;

EID: 77950863575     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2010.01.003     Document Type: Article

References (30)

1. Zalba G, Fortuno A, Diez J. Oxidative stress and atherosclerosis in early chronic kidney disease. Nephrol Dial Transplant 2006, 21:2686-2690.
2. Yeo FE, Villines TC, Bucci JR, Taylor AJ, Abbott KC Cardiovascular risk in stage 4 and 5 nephropathy. Adv Chronic Kidney Dis 2004, 11:116-133.
3. Lentine KL, Brennan DC, Schnitzler MA Incidence and predictors of myocardial infarction after kidney transplantation. J Am Soc Nephrol 2005, 16:496-506.
4. Ducloux D, Kazory A, Chalopin JM Predicting coronary heart disease in renal transplant recipients: a prospective study. Kidney Int 2004, 66:441-447.
5. Annuk M Which marker is informative in characterizing the level of oxidative stress in ESRD patient?. Nephron Clin Pract 2004, 98:c1-c2.
6. Vural A, Yilmaz M, Caglar K, et al. Assessment of oxidative stress in the early posttransplant period: comparison of cyclosporine A and tacrolimus-based regimens. Am J Nephrol 2005, 25:250-255.
7. Geraldi GM., Usberti M., Martini G, et al. Plasma total antioxidant capacity in hemodialyzed patients and its relationships to other biomarkers of oxidative stress and lipid peroxidation. Clin Chem Lab Med 2002, 40:104-110.
8. Witko-Sarsat V, Friedlander M, Capeillere-Blandin C, et al. Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 1996, 49:1304-1313.
9. Witko-Sarsat V, Friedlander M, Khoa TN, et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998, 161:2524-2532.
10. Witko-Sarsat V, Gausson V, Descamps-Latscha B Are advanced oxidation protein products potential uremic toxins?. Kidney Int Suppl 2003, 84:S11-S14.
11. Li HY, Hou FF, Zhang X, et al. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. J Am Soc Nephrol 2007, 18:528-538.
12. Tang IY, Meier-Kriesche HU, Kaplan B Immunosuppressive strategies to improve outcomes of kidney transplantation. Semin Nephrol 2007, 4:377-392.
13. Simmons EM, Langone A, Sezer MT, et al. Effect of renal transplantation on biomarkers of inflammation and oxidative stress in end-stage renal disease patients. Transplantation 2005, 79:914-919.
14. Campise M, Bamonti F, Novembrino C, et al. Oxidative stress in kidney transplant patients. Transplantation 2003, 76:1474-1478.
15. Antolini F, Valente F, Ricciardi D, Fagugli RM Normalization of oxidative stress parameters after kidney transplant is secondary to full recovery of renal function. Clin Nephrol 2004, 62:131-137.
16. Liu SW, Hou FF, Guo ZJ, et al. Advanced oxidation protein products accelerate atherosclerosis through promoting oxidative stress and inflammation. Arterioscler Tromb Vasc Biol 2006, 26:1156-1162.
17. Drueke T, Witko-Sarsat V, Massy Z, et al. Iron therapy, advanced oxidation protein products, and carotid artery intima-media thickness in end-stage renal disease. Circulation 2002, 106:2212-2217.
18. Kocak H., Gumuslu S, Ermis C, et al. Oxidative stress and asymmetric dimethylarginine is independently associated with carotid intima media thickness in peritoneal dialysis patients. Am J Nephrol 2008, 258:91-96.
19. Descamps-Latscha B, Witko-Sarsat V, Nguyen-Khoa T, et al. Advances oxidation protein products as risk factors for atherosclerotic cardiovascular events in nondiabetic predialysis patients. Am J Kidney Dis 2005, 454:39-47.
20. Kaneda H., Taguchi J, Ogasawara K, Aizawa T, Ohno M Increased level of advanced oxidation protein products in patients with coronary artery disease. Atherosclerosis 2002, 162:221-225.
21. Matsuda S, Koyasu S. Mechanism of action of cyclosporine. Immunopharmacology 2000, 47:119-125.
22. Gaston RS Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis 2001, 38(Suppl 6):25-35.
23. Han SY, Mun KC, Choi HJ, et al. Effects of cyclosporine and tacrolimus on oxidative stress in cultured mesangial cells. Transplant Proc 2006, 38:2240-2241.
24. Ghaznavi R., Zahmatkesh M, Kadkhodaee M, Mahdavi-Mazden M Cyclosporine effects on antioxidant capacity of rat renal tissues. Transplant Proc 2007, 39:866-867.
25. Mun KC, Lee KT, Choi HJ, et al. Effects of cyclosporine on production of the reactive oxygen species in the glial cells. Transplant Proc 2008, 40:2742-2743.
26. Jin KB, Choi HJ, Kim HT, et al. The production of reactive oxygen species in tacrolimus-treated glial cells. Transplant Proc 2008, 40:2680-2681.
27. Jin KB, Hwang EA, Han SY, et al. Effects of tacrolimus on antioxidant status and oxidative stress in glioma cells. Transplant Proc 2008, 40:2740-2741.
28. Calo LA, Davis PA, Giacon B, et al. Oxidative stress in kidney transplant patients with calcineurin inhibitor-induced hypertension: effect of ramipril. J Cardiovasc Pharmacol 2002, 40:625-631.
29. Perrea DN, Moulakakis KG, Poulakou MV, Vlachos IS, Papachristodoulou A, Kostakis AI Correlation between oxidative stress and immunosuppressive therapy in renal transplant recipients with an uneventful postoperative course and stable renal function. Int Urol Nephrol 2006, 38:343-348.
30. de Cal M, Silva S, Cruz D, et al. Oxidative stress and "monocyte reprogramming" after kidney transplant: a longitudinal study. Blood Purif 2008, 26:105-110.